Coherus BioSciences Inc (CHRS) — Cash Flow Reinvestment Rate
Coherus BioSciences Inc (CHRS) has a Cash Flow Reinvestment Rate of 0.02x as of December 2024, reinvesting $542.00K (capex $0.00 plus investments $-542.00K) from operating cash flow of $28.61 Million. Explore CHRS capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Coherus BioSciences Inc Cash Flow Reinvestment Rate (2013–2020)
Historical reinvestment intensity for Coherus BioSciences Inc across 3 annual periods. Also explore Coherus BioSciences Inc balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Coherus BioSciences Inc (2013–2020)
Year-by-year capital reinvestment analysis for Coherus BioSciences Inc. For live market cap and broader valuation context, see CHRS stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.05x | $7.39 Million | $154.15 Million | $7.23 Million | ▼ -89.6% |
| 2019 | 0.46x | $13.06 Million | $28.36 Million | $12.90 Million | ▲ +1804.8% |
| 2013 | 0.02x | $373.00K | $15.42 Million | $373.00K | — |